Classify each finding for a client receiving voriconazole by the medication-safety decision it supports.
Matrix
Choose your responses, then check the answer.
Explanation
Voriconazole requires review of liver injury, QT and electrolyte risk, major CYP interactions, visual effects, and route selection in renal impairment. Transient visual change is taught and monitored, while syncope with QT prolongation or jaundice requires prompt escalation.
Quick answer Sort route, interaction, monitoring, and urgent toxicity cues.
Why this is correct The intravenous formulation contains a solubilizing vehicle that can accumulate with impaired renal clearance. Voriconazole itself can also affect hepatic function, cardiac repolarization, vision, and concentrations of interacting drugs.
Easy analogy or mental picture Build a medication safety chain: identify the cue cluster, connect it to the drug mechanism, stop preventable exposure, stabilize the client, and verify the response with measurable findings.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving treatment for the underlying condition.
Why the other choices are wrong Options that rely on one reassuring value, continue a suspect exposure, bypass monitoring, or delay escalation leave the medication hazard active.
References
1DailyMed: VFEND (voriconazole) prescribing informationHepatic monitoring, QT risk, visual effects, interactions, and IV vehicle considerations in renal impairment
Medication-safety reviewVerify the indication, current assessment, laboratory trend, timing, route, interactions, authorized action, and measurable follow-up.